Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Compounding is essential for effective wealth building. Discover why it matters and how to incorporate it into your financial plans.
21,125 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
A well-known AI stock has retraced roughly a quarter from its high, creating a potential entry point for investors. T...
Gossamer Bio's 2026 earnings outlook centers on cash runway, pipeline progress, and strategic partnerships. This arti...
A three-way market story unfolds: the Dow climbs, Nasdaq retreats, and SpaceX headlines keep investors guessing. Here...
As 2026 politics intensify, Trump claims the U.S. economy is the strongest in history. This article weighs the data a...
A security breach at a leading crypto gift card platform on March 1 has security researchers weighing North Korean-li...
This article breaks down the expected path for synopsys (snps) 2026 earnings, focusing on AI design driver demand, li...
A trusted case worker exploited access to SNAP accounts, highlighting insider risk in public benefits. Learn how such...
As Home Depot gears up to report, investors weigh EPS targets, margin dynamics, and housing trends. This guide breaks...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
An Ouster director recently disclosed an open-market sale of thousands of shares. This deep dive explains what such m...
X-Energy stock faced a sharp 19.2% drop this week after project delays and a downgrade. This article breaks down the ...